Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
✍ Scribed by Chun–Jen Liu; Wan–Long Chuang; Chuan–Mo Lee; Ming–Lung Yu; Sheng–Nan Lu; Shun–Sheng Wu; Li–Ying Liao; Chi–Ling Chen; Hsing–Tao Kuo; You–Chen Chao; Shui–Yi Tung; Sien–Sing Yang; Jia–Horng Kao; Chen–Hua Liu; Wei–Wen Su; Chih–Lin Lin; Yung–Ming Jeng; Pei–Jer Chen; Ding–Shinn Chen
- Book ID
- 119760676
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 672 KB
- Volume
- 136
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis c virus (hcv) infection. we compared the efficacy and safety of peginterferon alfa-2a plus ribavirin,
Peginterferon plus ribavirin is standard therapy for adults with chronic hepatitis C. As no data are available for children, the aim of the study was to evaluate the efficacy and tolerability of peginterferon alfa-2b in combination with ribavirin in chronically infected children. Genotypes, alanine